Literature DB >> 1309932

A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.

H K Kashima1, F Shah, A Lyles, R Glackin, N Muhammad, L Turner, S Van Zandt, S Whitt, K Shah.   

Abstract

The clinical triad of a firstborn delivered vaginally to a young (teenage) mother has been previously noted among juvenile onset recurrent respiratory papillomatosis (JO-RRP) patients. This study was based on a questionnaire survey of JO-RRP patients, adult onset recurrent respiratory papillomatosis (AO-RRP) patients, and juvenile and adult controls. The survey results revealed that the complete or partial triad was observed in 72% of JO-RRP patients, 36% of AO-RRP patients, 29% of juvenile controls, and 38% of adult controls. As compared with juvenile controls, JO-RRP patients were more often firstborn (P less than .05), delivered vaginally (P less than .05), and born to a teenage mother (P less than .01). Among adult participants, AO-RRP patients reported more lifetime sex partners (P less than .01) and a higher frequency of oral sex (P less than .05) than reported by adult controls. AO-RRP and JO-RRP appear to have distinguishable epidemiologic features indicating that the mode of human papillomavirus (HPV) transmission is different in these two disorders.

Entities:  

Mesh:

Year:  1992        PMID: 1309932     DOI: 10.1288/00005537-199201000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  35 in total

1.  Case Report: Pulmonary Papillomatosis in a Patient Presenting with Cough and Hemoptysis.

Authors:  Zhou Zhang; Melisa Chang; Luis M Moreta-Sainz
Journal:  Perm J       Date:  2015

Review 2.  Oral sex and the transmission of viral STIs.

Authors:  S Edwards; C Carne
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

3.  Office-based Management of Recurrent Respiratory Papilloma.

Authors:  Kevin M Motz; Alexander T Hillel
Journal:  Curr Otorhinolaryngol Rep       Date:  2016-03-31

4.  In situ hybridization signal patterns in recurrent laryngeal squamous papillomas indicate that HPV integration occurs at an early stage.

Authors:  Erin Grace Brooks; Mark Francis Evans; Christine Stewart-Crawford Adamson; Zhihua Peng; Vanitha Rajendran; Rodolfo Laucirica; Kumarasen Cooper
Journal:  Head Neck Pathol       Date:  2011-11-05

5.  Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.

Authors:  Ben C Creelan; M Usman Ahmad; Frank J Kaszuba; Farah K Khalil; Allison W Welsh; Metin Ozdemirli; Nazaneen N Grant; Deepa S Subramaniam
Journal:  Oncologist       Date:  2019-03-06

6.  Extralaryngeal HPV infections in male patients with adult-onset laryngeal papillomatosis.

Authors:  Leena-Maija Aaltonen; Suvi Cajanus; Leif Bäck; Pekka Nieminen; Jorma Paavonen; Annamari Ranki
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-08-24       Impact factor: 2.503

Review 7.  Adjuvant antiviral therapy for recurrent respiratory papillomatosis.

Authors:  Neil K Chadha; Adrian James
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

8.  Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.

Authors:  R E A Tjon Pian Gi; T Ilmarinen; E R van den Heuvel; L M Aaltonen; J Andersen; J W Brunings; M Chirila; A Dietz; F Ferran Vilà; G Friedrich; H H W de Gier; W Golusinski; M Graupp; A Hantzakos; R Horcasitas; J Jackowska; J C Koelmel; G Lawson; F Lindner; M Remacle; C Sittel; V Weichbold; M Wierzbicka; F G Dikkers
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-03       Impact factor: 2.503

Review 9.  [Laryngeal papillomatosis: etiology, diagnostics and therapy].

Authors:  M Andratschke; C Betz; A Leunig
Journal:  HNO       Date:  2008-12       Impact factor: 1.284

10.  Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

Authors:  Anil K Chaturvedi; Ruth A Kleinerman; Allan Hildesheim; Ethel S Gilbert; Hans Storm; Charles F Lynch; Per Hall; Froydis Langmark; Eero Pukkala; Magnus Kaijser; Michael Andersson; Sophie D Fossa; Heikki Joensuu; Lois B Travis; Eric A Engels
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.